NCT06099340

Brief Summary

Neurological disorders \[such as Cerebral Vascular Accident (CVA) or Spinal Cord Injury (SCI)\] are among the most costly health problems to society in industrialized countries. For those affected, they generate severe restrictions in mobility, significantly altering their quality of life. Deterioration in motor function after stroke or BM is closely linked to the level of force produced at joint level. This is influenced by adaptations (neurological and tissue) inherent to the pathophysiology of the injury, and characterized by the presence of a spastic paresis syndrome. A great deal of effort is devoted to motor neurorehabilitation (particularly physiotherapy) in the days and weeks following neurological injury. This so-called sub-acute rehabilitation phase is designed to have a positive impact on the patient's motor recovery (to prevent the development of spastic paresis), and to prevent future severe limitations in the long term. Disorders observed in the chronic phase (partial recovery of strength, severe orthopedic deformities) demonstrate the limits of current therapies. In view of the results obtained in healthy subjects, eccentric training now seems to be one of the most promising physiotherapy methods for recovering muscle strength and countering neurological disorders. However, its use in the sub-acute rehabilitation phase has never been evaluated in post-stroke or post-BM patients, either in terms of its effects on the strength developed in the strengthened muscles, or more locally on the neurological and tissue disorders found in these patients in the context of spastic paresis. The aim of this project is to evaluate the effects of an eccentric muscle-strengthening exercise protocol on neurological patients in the sub-acute phase of their neurological impairment. The protocol will be applied to the ankle joint, given its importance for walking and the significant deficits found at this level in neurological populations.We hypothesize that the strengthening protocol will improve muscle strength at the ankle, and generate beneficial adaptations to combat the spastic paresis syndrome (improved muscle activation, increased muscle length, muscle volume, etc.).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
18mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Sep 2024Oct 2027

First Submitted

Initial submission to the registry

October 9, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 25, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

3.1 years

First QC Date

October 9, 2023

Last Update Submit

August 14, 2024

Conditions

Keywords

Neurological rehabilitationPhysiotherapyEccentric muscle strengtheningStrengthSpastic paresisStrokeSpinal cord injury

Outcome Measures

Primary Outcomes (1)

  • Maximum joint force moment

    The force-generating capacity of the plantar flexors will be studied by measuring the maximum joint force moment on an isokinetic ergometer

    10 weeks after the start of the muscle-strengthening protocol

Secondary Outcomes (2)

  • Measurement of joint force moment

    14 weeks after the start of the muscle-strengthening protocol

  • Measurement of joint force moment

    10 weeks after the start of the muscle-strengthening protocol

Study Arms (2)

Experimental " EXC "

EXPERIMENTAL

eccentric strengthening + conventional rehabilitation

Other: muscle-strengthening program

Comparator " CONC "

ACTIVE COMPARATOR

concentric strengthening + conventional rehabilitation

Other: muscle-strengthening program

Interventions

a muscle-strengthening program applied to the ankle muscles (triceps surae and dorsal flexors) in physiotherapy, as a complement to conventional rehabilitation

Comparator " CONC "Experimental " EXC "

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged between 18 and 80 years
  • Patient with stroke\< 6 months or Patient with spinal cord injury American Spinal Injury Association (ASIA) Impairment Scale C or D (incomplete motor impairment) \< 6 months (second secondary criterion).
  • Patient hospitalized for primary rehabilitation in the neurological PRM department of Nantes University Hospital.
  • Patient with voluntary motricity rated between 2 and 4 on the MRC (Medical Research Council) scale

You may not qualify if:

  • History of functional surgery \<3 months or intramuscular injection into plantar flexors \<6 months
  • Patient with osteoarticular lesions contraindicating rehabilitation
  • Patient unlikely to adhere to protocol (severe cognitive impairment) and/or non-compliant
  • Patient with a progressive pathology contraindicating efforts (syrinx, cancer, cardiovascular instability, etc.)
  • Minors, protected adults, adults unable to give consent or pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu de Nantes

Nantes, 44400, France

Location

MeSH Terms

Conditions

StrokeSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSpinal Cord DiseasesTrauma, Nervous SystemWounds and Injuries

Central Study Contacts

Guillaume Le Sant

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Prospective Randomized Open Blinded End-point
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2023

First Posted

October 25, 2023

Study Start

September 1, 2024

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

August 16, 2024

Record last verified: 2024-08

Locations